Thrivent Financial for Lutherans’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-10,000
| Closed | -$798K | – | 2559 |
|
|
2021
Q1 | $798K | Sell |
10,000
-40,722
| -80% | -$3.18M | ﹤0.01% | 2003 |
|
|
2020
Q4 | $4M | Sell |
50,722
-260
| -0.5% | -$15.2K | 0.01% | 945 |
|
|
2020
Q3 | $2.24M | Buy |
50,982
+40,735
| +398% | +$2.01M | 0.01% | 1087 |
|
|
2020
Q2 | $453K | Buy |
10,247
+457
| +5% | +$17.1K | ﹤0.01% | 1952 |
|
|
2020
Q1 | $351K | Hold |
9,790
| – | – | ﹤0.01% | 1905 |
|
|
2019
Q4 | $694K | Buy |
9,790
+248
| +3% | +$18K | ﹤0.01% | 1704 |
|
|
2019
Q3 | $714K | Sell |
9,542
-54
| -0.6% | -$4.58K | ﹤0.01% | 1629 |
|
|
2019
Q2 | $774K | Buy |
9,596
+195
| +2% | +$13.7K | ﹤0.01% | 1568 |
|
|
2019
Q1 | $629K | Buy |
9,401
+191
| +2% | +$14.5K | ﹤0.01% | 1675 |
|
|
2018
Q4 | $686K | Buy |
9,210
+662
| +8% | +$54.7K | ﹤0.01% | 1397 |
|
|
2018
Q3 | $787K | Buy |
8,548
+470
| +6% | +$44.8K | ﹤0.01% | 1443 |
|
|
2018
Q2 | $795K | Buy |
8,078
+55
| +0.7% | +$6.15K | ﹤0.01% | 1406 |
|
|
2018
Q1 | $894K | Sell |
8,023
-14,027
| -64% | -$1.57M | ﹤0.01% | 1299 |
|
|
2017
Q4 | $2.27M | Buy |
22,050
+435
| +2% | +$43.3K | 0.01% | 869 |
|
|
2017
Q3 | $2.04M | Sell |
21,615
-310
| -1% | -$24.5K | 0.01% | 852 |
|
|
2017
Q2 | $1.71M | Buy |
21,925
+1,520
| +7% | +$114K | 0.01% | 879 |
|
|
2017
Q1 | $1.63M | Buy |
20,405
+790
| +4% | +$62.8K | 0.01% | 927 |
|
|
2016
Q4 | $1.54M | Buy |
19,615
+1,160
| +6% | +$90.1K | 0.01% | 958 |
|
|
2016
Q3 | $1.44M | Buy |
18,455
+1,110
| +6% | +$80.5K | 0.01% | 986 |
|
|
2016
Q2 | $1.19M | Buy |
17,345
+750
| +5% | +$51.7K | 0.01% | 1032 |
|
|
2016
Q1 | $1.18M | Buy |
16,595
+1,250
| +8% | +$78.5K | 0.01% | 1029 |
|
|
2015
Q4 | $954K | Buy |
15,345
+470
| +3% | +$28.7K | ﹤0.01% | 1087 |
|
|
2015
Q3 | $843K | Buy |
14,875
+1,100
| +8% | +$58.2K | ﹤0.01% | 1012 |
|
|
2015
Q2 | $739K | Buy |
13,775
+700
| +5% | +$34K | ﹤0.01% | 930 |
|
|
2015
Q1 | $621K | Buy |
13,075
+200
| +2% | +$8.85K | ﹤0.01% | 1008 |
|
|
2014
Q4 | $557K | Buy |
12,875
+200
| +2% | +$8.17K | ﹤0.01% | 1061 |
|
|
2014
Q3 | $436K | Buy |
12,675
+350
| +3% | +$12.4K | ﹤0.01% | 1176 |
|
|
2014
Q2 | $451K | Buy |
12,325
+150
| +1% | +$5.09K | ﹤0.01% | 1183 |
|
|
2014
Q1 | $411K | Hold |
12,175
| – | – | ﹤0.01% | 1057 |
|
|
2013
Q4 | $413K | Buy |
12,175
+100
| +0.8% | +$3.46K | ﹤0.01% | 1073 |
|
|
2013
Q3 | $385K | Buy |
12,075
+300
| +3% | +$7.98K | ﹤0.01% | 1063 |
|
|
2013
Q2 | $266K | Buy |
+11,775
| New | +$255K | ﹤0.01% | 1275 |
|
Thrivent Financial for Lutherans's CMD Position: Q2 2021 in Review
Thrivent Financial for Lutherans sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 10,000 shares — an estimated $798K sold.
Thrivent Financial for Lutherans first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $4M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Thrivent Financial for Lutherans reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Thrivent Financial for Lutherans sold 10,000 Cantel Medical Corporation shares in Q2 2021, an estimated $798K.
- Thrivent Financial for Lutherans first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Thrivent Financial for Lutherans's Cantel Medical Corporation position peaked at $4M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Thrivent Financial for Lutherans's 13F filing for Q2 2021, filed 19 Aug 2021.